Hemo Organic Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 ,inter alia, to consider and approve 1. To consider and approve the ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Hemo Organic Ltd has informed BSE that its Board of Directors will meet on Friday, 14th November 2025 at 4:00 p.m. The key items on the agenda are: (a) approval of the Un-Audited Financial Results for the quarter and half year ended 30th September 2025 along with the Limited Review Report, and (b) consideration of a proposal to raise funds through instruments such as equity shares, convertible warrants, or other securities via preferential issue, private placement, or other permissible modes. The fund-raising proposal would be subject to shareholder and regulatory approvals as per SEBI (ICDR) Regulations, 2018. The company is listed under scrip code 524590 with ISIN INE422G01015.
The board meeting could result in a potential equity dilution for existing shareholders if the fund-raising proposal is approved, along with the routine Q2/H1 FY26 results declaration. Investors should watch for the outcome of the fund-raising plan, as the mode (preferential, private placement) will determine the impact on shareholding and stock price.